Australia's largest stock trading and investment forum Australia's #1 stock forum

EPN

Click for more information

0.00%

2.4¢ epsilon healthcare limited

Ann: Trading Halt, page-8

First 8 Last

Share
Profile

Follow
brendio

193 Posts.

23

17/09/21

12:40

Post #: 56147387
Share

Originally posted by Marek78: ↑

Thanks for that info @Wallfly.

Just so we're or I'm clear here..... This is an order purchased by Cannvalate from Valens that EPN have manufactured???

So under the recent agreement, EPN (THC Pharma) will pay Valens a management fee for this ~$500k order, yet they EPN take a royalty fee of 2.5% to 4% for all Valens customers.
Sounds like a money laundering operation to me, ha!

Hey @BobbyNorthcote, when was the last $5M purchase order in the Aus pot listed companies you've seen?
CAN claimed $15M in sales, but have since revised this down a couple times.

Note: reading the Valens Ann of 9th Sept again, medipharm platform yet to launch.

"The second agreement is a services agreement pursuant
to which Cannvalate will provide advice on matters including the launch of the Medimar platform,"

Expand

Let's be generous and say 4%. $500k x 4 % = $20k. The order may be material, but the revenue to EPN hardly is. And this for an agreement that is not yet at completion.

Still, it's a start. We need many more to stay afloat.

EPN Price at posting: 15.0¢ Sentiment: Sell Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

JBY

James Bay latest lithium player to pivot to other metals amidst lithium slump

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

ASX Market Update: Index pulls back from record highs | October 16, 2024

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

There are more pages in this discussion • 2 more messages in this thread...

First 8 Last

Add EPN (ASX) to my watchlist

SPONSORED BY